Investigations regarding the utility of prodigiosenes to treat leukemia
View/ Open
Date
2013Author
Smithen, Deborah A.
Forrester, A. Michael
Corkery, Dale P.
Dellaire, Graham
Colpitts, Julie
McFarland, Sherri A.
Berman, Jason N.
Thompson, Alison
Metadata
Show full item recordAbstract
Prodigiosenes, possessing a 4-methoxypyrrolyldipyrrin skeleton, are known for their anti-cancer
activity. Structural modification of the C-ring resulted in a series of prodigiosenes that displayed
promising activity against leukemia cell lines during in vitro analysis against the NCI 60 cancer
cell line panel. Further in vivo studies of these compounds using the zebrafish model showed
persistence of anti-leukemia properties in human K562 chronic myelogenous leukemia cells.
Citation
Smithen, Deborah A., A. Michael Forrester, Dale P. Corkery, Graham Dellaire, et al. 2013. "Investigations regarding the utility of prodigiosenes to treat leukemia." Organic & Biomolecular Chemistry 11(1): 62-68.